COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,788 Articles (22,946 medRxiv, 8,842 bioRxiv)

Most recent first Previous |  Page 1693: Articles 16921-16930  | Next

Mendelian randomisation identifies alternative splicing of the FAS death receptor as a mediator of severe COVID-19
Klaric, L., Gisby, J. S., Papadaki, A., Muckian, M. D., Macdonald-Dunlop, E., Zhao, J. H., Tokolyi, A., Persyn, E., Pairo-Castineira, E., Morris, A. P., Kalnapenkis, A., Richmond, A., Landini, A., Hedman, A. K., Prins, B., Zanetti, D., Wheeler, E., Kooperberg, C., Yao, C., Petrie, J. R., Fu, J., Folkersen, L., Walker, M., Magnusson, M., Eriksson, N., Mattsson-Carlgren, N., Timmers, P. R., Hwang, S.-J., Enroth, S., Gustafsson, S., Vosa, U., Chen, Y., Siegbahn, A., Reiner, A., Johansson, A., Thorand, B., Gigante, B., Hayward, C., Herder, C., Gieger, C., Langenberg, C., Levy, D., Zhernakova, D. V., Smith, J. G., Campbell, H., Sundstrom, J., Danesh, J., Michaëlsson, K., Suhre, K., Lind, L., Wallentin, L., Padyukov, L., Landen, M., Wareham, N. J., Göteson, A., Hansson, O., Eriksson, P., Strawbridge, R. J., Assimes, T. L., Esko, T., Gyllensten, U., Baillie, J. K., Paul, D. S., Joshi, P. K., Butterworth, A. S., Mälarstig, A., Pirastu, N., Wilson, J. F., Peters, J. E.
10.1101/2021.04.01.21254789 — Posted: 2021-04-07
Co-circulation of SARS-CoV-2 variants B.1.1.7 and P.1
Stefanelli, P., Trentini, F., Guzzetta, G., Marziano, V., Mammone, A., Poletti, P., Molina Grane', C., Manica, M., del Manso, M., Andrianou, X., Pezzotti, P., Ajelli, M., Rezza, G., Brusaferro, S., Merler, S., COVID-19 National Microbiology Surveillance Study Group
10.1101/2021.04.06.21254923 — Posted: 2021-04-07
Predicting the severity of disease progression in COVID-19 at the individual and population level: A mathematical model
Chirmule, N., Nair, P., Desai, B., Khare, R., Nerurkar, V. R., Gaur, A.
10.1101/2021.04.01.21254804 — Posted: 2021-04-07
A prospective observational safety study on ChAdOx1 nCoV- 19 corona virus vaccine (recombinant) use in healthcare workers- first results from India
Kaur, U., Ojha, B., Pathak, B. K., Singh, A., Giri, K. R., Singh, A., Das, A., Misra, A., Yadav, A. K., Chakrabarti, S. S., Kansal, S.
10.1101/2021.04.03.21254823 — Posted: 2021-04-07
Detection of two CAL.20C SARS-CoV-2 variants in Monterrey metropolitan area in Northeast Mexico
Galan-Huerta, K. A., Rivas-Estilla, A. M., Lozano-Sepulveda, S. A., Martinez-Acuna, N., Arellanos-Soto, D., Montes-de-Oca-Luna, R., Trevino-Garza, C., De-la-O-Cavazos, M. E., Ramos-Jimenez, J.
10.1101/2021.04.05.21251104 — Posted: 2021-04-07
Covid-19 does not look like what you are looking for: clustering symptoms by nation and multi- morbidities reveal substantial differences to the classical symptom triad
Kadirvelu, B., Burcea, G., Quint, J., Costelloe, C. E., Faisal, A. A.
10.1101/2021.04.02.21254818 — Posted: 2021-04-07
Quantification of specific antibodies against SARS-CoV-2 in breast milk of lactating women vaccinated with an mRNA vaccine
Esteve-Palau, E., Gonzalez-Cuevas, A., Guerrero, M. E., Garcia-Terol, C., Alvarez, M. C., Garcia-Aranda, G., Casadevall, D., Diaz-Brito, V.
10.1101/2021.04.05.21254819 — Posted: 2021-04-07
Association of HIV with COVID-19 Outcomes Among Hospitalized Adults
Durstenfeld, M. S., Sun, K., Ma, Y., Rodriguez, F., Secemsky, E. A., Parikh, R. V., Hsue, P. Y.
10.1101/2021.04.05.21254938 — Posted: 2021-04-07
The SARS-CoV-2 Nsp3 macrodomain reverses PARP9/DTX3L-dependent ADP-ribosylation induced by interferon signalling
Russo, L. C., Tomasin, R., Matos, I. A., Manucci, A. C., Sowa, S. T., Dale, K., Caldecott, K. W., Lehtiö, L., Schechtman, D., Meotti, F. C., Bruni-Cardoso, A., Hoch, N. C.
10.1101/2021.04.06.438552 — Posted: 2021-04-07
Outcomes of COVID-19 Vaccination Efforts in Florida from December 14, 2020 to March 15, 2021 on Older Individuals
Rivkees, S., Roberson, S., Blackmore, C.
10.1101/2021.04.05.21254722 — Posted: 2021-04-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).